Skip to search.
 TSX Down 0.59% TSX Ventures Down 0.58%

Sequenom Inc. (SQNM)

-NasdaqGS
2.39 Down 0.01(0.21%) Aug 31, 4:00PM EDT
Prev Close:2.40
Open:2.39
Bid:2.38 x 20000
Ask:2.40 x 200
1y Target Est:1.35
Beta:1.92424
Earnings Date:Nov 2 - Nov 7 (Est.)
Day's Range:2.39 - 2.40
52wk Range:0.82 - 2.53
Volume:850,203
Avg Vol (3m):2,112,700
Market Cap:284.99M
P/E (ttm):N/A
EPS (ttm):-0.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SQNMDown 0.21%284.99M
LHDown 0.51%14.01B
PKIDown 0.95%5.83B
ILMNDown 0.38%24.68B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.49
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.30
Quarterly EPS Est (Sep-16) :-0.06
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):-0.32

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sequenom, Inc., a life sciences company, develops and commercializes molecular diagnostics testing services for the women's health and oncology markets in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback